Developer docs
API playgroundTry for free, no card

Search company profiles

Trials24

Full company profile

uuid000f9kc

Namestring
Trials24
Websiteurl
trials24.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Trials24 is a Munich, Germany-based, privately-held for-profit company founded in 2017 that operates in the online patient recruitment segment of the clinical-trial services market. According to its firmographic profile, Trials24 accelerates patient recruitment for clinical trials worldwide with an explicit mission to help study sites find patients they otherwise cannot reach, targeting the well-documented enrollment bottleneck where the majority of clinical trials miss recruitment timelines. The company reports a headcount of 11-50 employees, consistent with an early-to-mid stage commercial operation, and its primary web presence is at trials24.com.

Publicly disclosed detail on Trials24's specific product suite, underlying technology stack, pricing, customer roster, partnership network, and revenue trajectory is not present in the source material. The bulk of the aggregated source data set describes SubjectWell (subjectwell.com) — a separate, materially larger patient-recruitment platform — rather than Trials24, and that operational profile cannot be attributed to Trials24 without further confirmation. The lone directly-attributable technological signal for Trials24 is the use of AI-powered agents to screen patients, verify eligibility, and facilitate scheduling within clinical-trial recruitment workflows, indicating AI is embedded as a workflow-level feature rather than a proprietary foundation.

Trials24's go-to-market is consistent with a direct B2B sales motion targeting sponsors, contract research organizations (CROs), and investigative sites — a standard commercial pattern for this category — but no specific customer logos, contract sizes, or sales channels are documented. Trial24's reported leadership includes a Marketing and Communications Manager (Bohdana Demianenko); no further executive or board detail is provided.

Short descriptiontext

Trials24 is a Munich-based privately-held company founded in 2017 that provides online patient recruitment services for clinical trials worldwide, helping study sites find patients they cannot otherwise reach.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMünchen, Germany
HQ citystring
München
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
clinical trial recruitment, patient recruitment services, clinical research technology, patient recruitment platform, site enablement services
Industry3 codes
PRIMARYHLAGACAD
Clinical Trial Patient Recruitment & Retention
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLACAOAK
Patient Recruitment, Retention & Engagement for Trials
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Health Services8000
Product category
Clinical Trial Patient Recruitment Technology
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Patient Recruitment Services
TypeSubscription Recurring
Description

Provides patient recruitment solutions to sponsors, CROs, and sites. Services include full-site support, patient care and trial retention, virtual waiting room, recruitment simulation, secondary screening, and translations.

subjectwell.com
2Commercial Solutions
TypeSubscription Recurring
Description

Brand Connect solutions enabling brand marketers and agencies to leverage engaged patient populations for direct product marketing.

subjectwell.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise/sponsor pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed

subjectwell.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Trials24 accelerates online patient recruitment for clinical trials by connecting sponsors, CROs, and clinical sites with a 15 million+ patient network and AI-driven screening tools. It supplements this software platform with clinically trained, multilingual Patient Companions who handle administrative support, eligibility phone screening, transportation logistics, medical records retrieval, scheduling, and retention outreach. Additional services cover virtual waiting room management, recruitment simulation, secondary screening, and translations of IRB/EC-approved recruitment materials.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 30% enrollment acceleration potential
+3 more records
Product overview1 text field

SubjectWell offers a unified platform-plus-services architecture centered on the SubjectWell+ Platform, a comprehensive patient recruitment and site enablement solution. The platform integrates with multiple service modules including Study Connect and Direct Connect for patient recruitment, and Brand Connect for commercial marketing. Supporting these are complementary services such as Full-Site Support, Patient Care & Trial Retention, Virtual Waiting Room, Recruitment Simulation, Secondary Screening, and Translations, all delivered through clinically trained Patient Companions and designed to reduce site and patient burden throughout the clinical trial lifecycle.

Product and service7 records
1SubjectWell+ Platform
CategoryPatient recruitment platform
Description

Core technology platform for clinical trial patient recruitment and site enablement, combining the 15M+ Patient Network, AI-driven screening, eligibility verification, scheduling, and integrated service modules for sponsors, CROs, and sites.

2Full-Site Support
CategorySite enablement service
Description

Standalone service relieving site administrative burden through Patient Companions who handle patient communication, transportation logistics, medical records retrieval and review, phone screening for eligibility assessment, and site visit scheduling.

3Patient Care & Trial Retention
CategoryPatient retention service
Description

End-to-end service supporting patients throughout the clinical trial process through study close, ensuring patient engagement and retention across the trial lifecycle.

4Virtual Waiting Room
CategoryPatient engagement service
Description

Service that keeps patients engaged and prepared when sites are overloaded or not yet ready, managing complex dependencies such as CAR-T, lab results, or flare-ups while reducing dropouts.

5Recruitment Simulation
CategoryRecruitment analytics service
Description

Service that gathers insights to improve the patient experience during the patient recruitment process for clinical trials.

6Secondary Screening
CategoryPatient screening service
Description

Service that reduces site effort and time by having Patient Companions schedule the site screening call for patients.

7Translations
CategoryTranslation service
Description

Translation service for IRB/EC-approved English trial recruitment materials into required languages to support global and multi-country study onboarding.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnerships with site networks to streamline patient enrollment and reduce site burden. SubjectWell supports these networks with their technology platform and patient recruitment services.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnerships with Contract Research Organizations to integrate patient recruitment services seamlessly with CRO operational processes and accelerate study timelines.

Peers8 records
1Mendel.ai
TypeEmerging player
Description

Mendel.ai applies AI/structured-data extraction to clinical-trial patient matching, representing an emerging AI-native competitor whose technology trajectory could overlap with Trials24's recruitment workflow.

TypeBroad incumbent
Description

Parexel is a global CRO with integrated patient-recruitment services within its full-service clinical trial offerings, directly contesting Trials24's positioning at enterprise sponsor accounts.

TypeDirect peer
Description

Clariness is a Hamburg-based clinical trial patient recruitment company with a comparable European footprint and sponsor base, making it the closest geographic and service-line peer to Trials24.

TypeDirect peer
Description

Antidote is a digital patient-recruitment company using structured matching to connect patients to clinical trials, providing directly comparable online recruitment services to Trials24's offerings.

5Deep 6 AI
TypeEmerging player
Description

Deep 6 AI uses AI to mine structured and unstructured EHR data for clinical-trial patient identification, intersecting with Trials24's mission via a more technology-centric, less service-heavy approach.

TypeDirect peer
Description

SubjectWell operates a 15M+ patient network and a SubjectWell+ platform for clinical-trial patient recruitment, addressing the same problem as Trials24 and serving the same sponsor/CRO/site buyer base.

TypeDirect peer
Description

BBK Worldwide is an established patient-recruitment and engagement agency serving global trials, with overlapping services (referral, retention, site support) and a comparable sponsor customer base to Trials24.

TypeBroad incumbent
Description

IQVIA is a global full-service CRO that includes patient recruitment as part of its broader clinical operations portfolio, representing a major incumbent that competes at the sponsor level against Trials24.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Trials24

Clinical Trial Patient Recruitment Technologytrials24.com

Trials24 is a Munich-based privately-held company founded in 2017 that provides online patient recruitment services for clinical trials worldwide, helping study sites find patients they cannot otherwise reach.

What Trials24 does

Trials24 is a Munich, Germany-based, privately-held for-profit company founded in 2017 that operates in the online patient recruitment segment of the clinical-trial services market. According to its firmographic profile, Trials24 accelerates patient recruitment for clinical trials worldwide with an explicit mission to help study sites find patients they otherwise cannot reach, targeting the well-documented enrollment bottleneck where the majority of clinical trials miss recruitment timelines. The company reports a headcount of 11-50 employees, consistent with an early-to-mid stage commercial operation, and its primary web presence is at trials24.com.

Publicly disclosed detail on Trials24's specific product suite, underlying technology stack, pricing, customer roster, partnership network, and revenue trajectory is not present in the source material. The bulk of the aggregated source data set describes SubjectWell (subjectwell.com) — a separate, materially larger patient-recruitment platform — rather than Trials24, and that operational profile cannot be attributed to Trials24 without further confirmation. The lone directly-attributable technological signal for Trials24 is the use of AI-powered agents to screen patients, verify eligibility, and facilitate scheduling within clinical-trial recruitment workflows, indicating AI is embedded as a workflow-level feature rather than a proprietary foundation.

Trials24's go-to-market is consistent with a direct B2B sales motion targeting sponsors, contract research organizations (CROs), and investigative sites — a standard commercial pattern for this category — but no specific customer logos, contract sizes, or sales channels are documented. Trial24's reported leadership includes a Marketing and Communications Manager (Bohdana Demianenko); no further executive or board detail is provided.

Trials24 firmographics

Firmographics
Name
Trials24
Website
https://trials24.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Trials24 is a Munich-based privately-held company founded in 2017 that provides online patient recruitment services for clinical trials worldwide, helping study sites find patients they cannot otherwise reach.
Ownership category
akta.pro rank

Trials24 industry classification

Industry
Product category
Clinical Trial Patient Recruitment Technology
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGACAD
Clinical Trial Patient Recruitment & Retention
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLACAOAK
Patient Recruitment, Retention & Engagement for Trials
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Clinical trial recruitment
  • Patient recruitment services
  • Clinical research technology
  • Patient recruitment platform
  • Site enablement services

Where Trials24 is headquartered

Location

Headquarters

HQ city
München
HQ country
Germany
HQ region
Europe

Markets served

Trials24 business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Patient Recruitment Services: Provides patient recruitment solutions to sponsors, CROs, and sites. Services include full-site support, patient care and trial retention, virtual waiting room, recruitment simulation, secondary screening, and translations.
  2. Commercial Solutions: Brand Connect solutions enabling brand marketers and agencies to leverage engaged patient populations for direct product marketing.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise/sponsor pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Trials24 product offering

Product offering

Core offering

Trials24 accelerates online patient recruitment for clinical trials by connecting sponsors, CROs, and clinical sites with a 15 million+ patient network and AI-driven screening tools. It supplements this software platform with clinically trained, multilingual Patient Companions who handle administrative support, eligibility phone screening, transportation logistics, medical records retrieval, scheduling, and retention outreach. Additional services cover virtual waiting room management, recruitment simulation, secondary screening, and translations of IRB/EC-approved recruitment materials.

Product overview

SubjectWell offers a unified platform-plus-services architecture centered on the SubjectWell+ Platform, a comprehensive patient recruitment and site enablement solution. The platform integrates with multiple service modules including Study Connect and Direct Connect for patient recruitment, and Brand Connect for commercial marketing. Supporting these are complementary services such as Full-Site Support, Patient Care & Trial Retention, Virtual Waiting Room, Recruitment Simulation, Secondary Screening, and Translations, all delivered through clinically trained Patient Companions and designed to reduce site and patient burden throughout the clinical trial lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

  • SubjectWell+ Platform Core technology platform for clinical trial patient recruitment and site enablement, combining the 15M+ Patient Network, AI-driven screening, eligibility verification, scheduling, and integrated service modules for sponsors, CROs, and sites.
  • Full-Site Support Standalone service relieving site administrative burden through Patient Companions who handle patient communication, transportation logistics, medical records retrieval and review, phone screening for eligibility assessment, and site visit scheduling.
  • Patient Care & Trial Retention End-to-end service supporting patients throughout the clinical trial process through study close, ensuring patient engagement and retention across the trial lifecycle.
  • Virtual Waiting Room Service that keeps patients engaged and prepared when sites are overloaded or not yet ready, managing complex dependencies such as CAR-T, lab results, or flare-ups while reducing dropouts.
  • Recruitment Simulation Service that gathers insights to improve the patient experience during the patient recruitment process for clinical trials.
  • Secondary Screening Service that reduces site effort and time by having Patient Companions schedule the site screening call for patients.
  • Translations Translation service for IRB/EC-approved English trial recruitment materials into required languages to support global and multi-country study onboarding.

Quantifiable outcome

  • 30% enrollment acceleration potential
  • +3 more outcomes

Companies that use Trials24

Customer profile

Segments4 records

Ideal customer profiles4 records

Trials24 technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature5 records

Trials24 partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Site NetworkscoreStrategic or Co-development PartnerStrategic partnerships with site networks to streamline patient enrollment and reduce site burden. SubjectWell supports these networks with their technology platform and patient recruitment services.
  • CRO PartnerscoreStrategic or Co-development PartnerPartnerships with Contract Research Organizations to integrate patient recruitment services seamlessly with CRO operational processes and accelerate study timelines.

Scale indicators12 records

Trials24 competitors and assessment

Company assessment

Emerging players

  • Mendel.ai: Mendel.ai applies AI/structured-data extraction to clinical-trial patient matching, representing an emerging AI-native competitor whose technology trajectory could overlap with Trials24's recruitment workflow.
  • Deep 6 AI: Deep 6 AI uses AI to mine structured and unstructured EHR data for clinical-trial patient identification, intersecting with Trials24's mission via a more technology-centric, less service-heavy approach.

Broad incumbents

  • Parexel: Parexel is a global CRO with integrated patient-recruitment services within its full-service clinical trial offerings, directly contesting Trials24's positioning at enterprise sponsor accounts.
  • IQVIA: IQVIA is a global full-service CRO that includes patient recruitment as part of its broader clinical operations portfolio, representing a major incumbent that competes at the sponsor level against Trials24.

Direct peers

  • Clariness: Clariness is a Hamburg-based clinical trial patient recruitment company with a comparable European footprint and sponsor base, making it the closest geographic and service-line peer to Trials24.
  • Antidote: Antidote is a digital patient-recruitment company using structured matching to connect patients to clinical trials, providing directly comparable online recruitment services to Trials24's offerings.
  • SubjectWell: SubjectWell operates a 15M+ patient network and a SubjectWell+ platform for clinical-trial patient recruitment, addressing the same problem as Trials24 and serving the same sponsor/CRO/site buyer base.
  • BBK Worldwide: BBK Worldwide is an established patient-recruitment and engagement agency serving global trials, with overlapping services (referral, retention, site support) and a comparable sponsor customer base to Trials24.

Market position

Strengths4 records

Weaknesses4 records

Key risks4 records

Key highlights4 records

Customer concentration

Trials24 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Trials24 leadership team

Management profile

Number of profiles

Profiles1 record

Trials24 funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Trials24 M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trials24

What does Trials24 do?

Trials24 accelerates online patient recruitment for clinical trials by connecting sponsors, CROs, and clinical sites with a 15 million+ patient network and AI-driven screening tools. It supplements this software platform with clinically trained, multilingual Patient Companions who handle administrative support, eligibility phone screening, transportation logistics, medical records retrieval, scheduling, and retention outreach. Additional services cover virtual waiting room management, recruitment simulation, secondary screening, and translations of IRB/EC-approved recruitment materials.

When was Trials24 founded?

Trials24 was founded in 2017. It employs 11 to 50 people.

Where is Trials24 based?

Trials24 is headquartered in München, Germany, in the Europe region.

How does Trials24 make money?

Two revenue lines are on record. Patient Recruitment Services are the primary driver. The others are commercial Solutions.

Who are Trials24's main competitors?

Emerging players on record are Mendel.ai and Deep 6 AI. Broad incumbents are Parexel and IQVIA. Direct peers are Clariness, Antidote, SubjectWell and BBK Worldwide.

Does Trials24 have an API?

No public API is recorded for Trials24.

What industry is Trials24 in?

Trials24's product category is Clinical Trial Patient Recruitment Technology. Its primary akta.pro industry code is HLAGACAD, Clinical Trial Patient Recruitment & Retention, with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 5417 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogSubjectWell announces strategic acquisition of Trials24 to expand global patient recruitment capabilitiesSubjectWell acquired Trials24, a global digital patient recruitment provider, to expand its recruitment capabilities. The integration combines SubjectWell's 13 million patient network with Trials24's engagement centers in over 13 European countries. The companies have begun integrating, with no impact on customer or patient engagements.Trials24SubjectWell announces strategic acquisition of Trials24 to expand global patient recruitment capabilitiesSubjectWell announced the strategic acquisition of Trials24, a provider of global digital patient recruitment solutions, on September 17, 2024. The integration aims to combine SubjectWell's network of over 13 million patients with Trials24's technology and engagement centers in more than 13 European countries to expand global reach. This move is designed to enhance diversity in clinical trials and improve access to treatments for patients worldwide.SubjectwellSubjectWell Announces Strategic Acquisition of Trials24 to Expand Global Patient Recruitment CapabilitiesSubjectWell announced the acquisition of Trials24 to expand its global patient recruitment capabilities for clinical trials. The integration combines SubjectWell's network of over 13 million patients with Trials24's digital marketing expertise and engagement centers in more than 13 European countries. Both companies have begun integrating their operations to enhance global reach and diversity in clinical research.